Document is current
Any future updates will be listed below
-
Authors
Jiménez-Morales, Antonia https://orcid.org/0000-0002-9861-2309
Solís-Garrido, Ángela https://orcid.org/0009-0003-4938-1262
Toirac, Beatriz
Mediero, Aranzazu
Costa, Bruna
Mulero, Francisca
Murillo, Óscar
Monclús, Miguel https://orcid.org/0000-0003-3421-3322
Esteban, Jaime
Aguilera-Correa, John Jairo https://orcid.org/0000-0002-4002-1944
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 25 March 2025
First Online: 10 April 2025
Competing interests
: J.E. received travel grants from Pfizer and conference fees from bioMérieux and Heraeus. The funders had no role in the design of the study, the collection, analyses, or interpretation of data; the writing of the manuscript, or in the decision to publish the results. The remaining authors declare no conflict of interest. The antibiotics-loaded sol–gel used in this study is one of the products protected by the patent entitled Procedure for Obtaining a Sol–Gel Coating, Composition Coating and Use of the Same; P201730628; Antonia Jiménez Morales, Amaya García Casas, Jaime Esteban Moreno, John Jairo Aguilera Correa; Spain. The use of dipyridamole as a novel osteostimulant therapy in this study is one of the products protected by the patent entitled Tissue repair devices and scaffolds; 20160262894; Brouce N. Cronstein, Aranzazu Mediero Muñoz, John Ricci, Stephen Ishack; United States.
